Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference
Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.
Major Announcement: First HD patients treated with gene silencing drugs
HDBuzz untangles hope from hype in clinical trial announcements
How will we know whether HD-lowering treatments are working? New advancements in the detection of mutant huntingtin.
Day 2 of updates from the annual HD Therapeutics Conference in Palm Springs
A new study shows a synthetic oil called triheptanoin changes how HD brains use energy. But will it help HD?
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.